Skip to main content
Loading ResearchHub…
References for Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial | ResearchHub - ResearchHub